PHOTO
The Egyptian Tax Authority (ETA) has issued a decision, upon which it approved that the services offered by the Egyptian Drug Authority (EDA) will be now subject to the 14% value-added tax (VAT), according to a statement released by EDA.
This decision has been effective starting from August 1st, 2021, the EDA added in the statement.
Accordingly, the 14% VAT will be imposed on all the services carried out by the EDA, including licensing products, performing tests, and supervising drug production.
Copyright © 2021 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
